Absci Corporation (ABSI) is scheduled to report first-quarter 2024 results on May 14. Let's see how things might have shaped up prior to the announcement. Factors to Consider Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients. The company primarily generates revenues from drug-creation activities. ABSI is still early in the adoption phase of its drug creation model. Hence, investors will mostly focus on pipeli ...